Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (14603)	9/13/1998 5:26:00 PM
From: BoNg-N-BoNg	Respond to of 120523

Jenna, just like you, I'm also disappointed on internet stocks in general last friday... I was thinking it will be them to rebound first but as Jerry said it "money rotation out of internet stocks"...Lots of them are beaten down but some of them deserves to rebound.. I see AOL, YHOO, SEEK, CMGI as the watch lists for this week to catch up w/ the big caps.... and it looks like CMGI has the potential biggest gainer of all of them... good luck.. just me.. eL....

To: Jenna who wrote (14603)	9/13/1998 5:49:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

. e-mail: FLEXF, BGEN, LBOR FLEXF was already discussed. Here is a reprint. exchange2000.com BGEN..As for BGEN.. Technicals: Stochastics show stock is OVERBOUGHT STOCK did break double top P & F chart formation. I don't expect to initiate a new position in this right way. I expect for the long haul this company should do marvelous. Avonex has 60% market share in the U.S.. And now its in Europe. There are new drugs in their pipeline. Value line says "surging Avoncex sales and growing royalty revenues should keep Biogen's profits rising strongly through 1999. As far as fundamentals go however it has a estimate of $.47 versus $0.41 from last quarter. Revenues in the latest quarter, were up 39% to $135.8 million vs. $97.7 million EPS grew 57% to $.41 vs. $16 in the same period last year. It is rated a buy by OTC Insight, Timer Digest, Value Line gives it a "1" for timeliness. The Oberweiss report just gives it an immediate buy recommendation. I became attracted to this stock when my mutual fund picked up a large amount of it. AMGN, CNTO and BGEN did very well as did AVEI, while at the same time brokerages and financials were stricken with 40-50% losses. Everyone who 'reassured' me that GE,LEH and MER would not drop that much were proven wrong. I think there will probably be a pop in the entire biotech sector. Perhaps its the time for the biotechs and oil services to shine if only briefly. LBOR.. I'm disturbed about this stock.. look what happened with REXI it never really rebounded. If the allegations are true you could see LBOR trading at 6 or 7... I would not be buying up positions waiting for it to come back. I would take LBOR on a day to day basis perhaps a 1-2 day hold, but to actually invest in this would be extremely risky.